A rare holiday treat--two sets of research summaries in one day, and a partridge in a pear tree.
Read More
Christmas is coming and my present to you is a lump of coal in the form of research summaries.
Read More
Hospital length of stay analysis shows some kind of interesting trends.
Read More
A non-Moronic variant version of research summaries.
Read More
The Moronic variant has reached our shores and the research can't be far behind, and as usual we are right on top of it.
Read More
Trust me, there is no reason to panic over the Moronic strain; in fact there was never any reason to panic about anything in the epidemic.
Read More
Another Monday drop of breakthru event data and our resulting updated table of proportions.
Read More
Our best shot at relative risk of infection for the unvaxed, the vaxed and the prior infected.
Read More
Livongo was one of the hottest "digital" health companies, and investors may feel like they got a certain digit from the company, as Cigna drops it as a preferred vendor and the company's acquisition by Teladoc for an outrageous sum also look like less than a brilliant move. Two overpriced companies do not make one fairly valued one.
https://digitalhealth.modernhealthcare.com/information-technology/cigna-drops-livongo-preferred-digital-health-tool?utm_source=digital-health-intel&utm_medium=email&utm_campaign=20211220&utm_content=article1-headlineLarge database firm Oracle is buying electronic medical records and administrative software vendor Cerner for $28.3 billion, a move that likely is aimed at further penetration in a heavy software use industry and at competitor Salesforce.
https://www.statnews.com/2021/12/20/oracle-cerner-health-records-cloud/?utm_source=STAT+Newsletters&utm_campaign=07bd9ab023-Daily_Recap&utm_medium=email&utm_term=0_8cab1d7961-07bd9ab023-152470873Opening your holiday week with a cheery observation and some research summaries to stick in your stocking.
Read More
Another look at year-over-year experience with the epidemic.
Read More
